Comment on

• Immunogenicity of quadrivalent HPV vaccine among girls 11 to 13 Years of age vaccinated using alternative dosing schedules: results 29 to 32 months after third dose.

  Lamontagne DS, Thiem VD, Huong VM, Tang Y, Neuzil KM. Lamontagne DS, et al. J Infect Dis. 2013 Oct 15;208(8):1325-34. doi: 10.1093/infdis/jit363. Epub 2013 Jul 30. J Infect Dis. 2013. PMID: 23901077
• Conclusions about the quadrivalent human papillomavirus vaccine efficacy based on alternate dosing schedules and less than three dose immunogenicity is inappropriate.

  Harper DM. Harper DM. J Infect Dis. 2014 Jul 15;210(2):330-1. doi: 10.1093/infdis/jiu072. Epub 2014 Feb 5. J Infect Dis. 2014. PMID: 24501212 No abstract available.